Table 2. Effects of stress pathway component perturbations on gst-4p::gfp expression.
| Genotype | GST-4::GFP levels | |
|---|---|---|
| Untreated | Acrylamide | |
| Wild-type | − | ++ |
| alh-6(k1018) | ++ | +++ |
| xrep-4(k1024) | − | − |
| skr-1/2(RNAi) | − | − |
| wdr-23(k1007) | +++ | N.D. |
| skn-1(k1023)(gof) | +++ | N.D. |
| skn-1(RNAi) | − | − |
| alh-6(k1018); skr-1/2(RNAi) | − | N.D. |
| alh-6(k1018); skn-1(RNAi) | − | N.D. |
| xrep-4(k1024); alh-6(RNAi) | − | N.D. |
| xrep-4(k1024); wdr-23(RNAi) | +++ | N.D. |
| xrep-4(RNAi); skn-1(k1023)(gof) | +++ | N.D. |
| skn-1(k1023)(gof); skn-1(RNAi) | − | − |
N.D., not determined.